mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.009 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.01 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |